Nicotinic acid esters useful as CNS agents and having affinity for 5-HT receptors
申请人:Pharmacia AB
公开号:EP1120410A1
公开(公告)日:2001-08-01
The present invention concerns novel compounds of formula (II) wherein R is selected from saturated or unsaturated alkyls, saturated or unsaturated cycloalkyls, heterocyclic compounds or from (a) or (b) wherein G is carbon or nitrogen; m is 0-10; wherein R1, R2 and R3 are the same or different and selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl and the pharmacologically active salts thereof. The new compounds can be used for treating disorder in the central nervous system.
本发明涉及式(II)的新型化合物 其中 R 选自饱和或不饱和烷基、饱和或不饱和环烷基、杂环化合物或选自(a)或(b) 其中 G 为碳或氮;m 为 0-10;其中 R1、R2 和 R3 相同或不同,选自氢、卤素、1-5 个碳原子的烷基、电子供体基团如 1-5 个碳原子的烷氧基或羟基、选自氰基、硝基、三氟烷基的电子受体基团及其药理活性盐。新化合物可用于治疗中枢神经系统疾病。